Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Opioid Shipment Verification Violations

The U.S. Food and Drug Administration (FDA) issued a warning letter to McKesson alleging “significant violations” of verification requirements designed to protect the public from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. According to the FDA, in June 2016, a pharmacy reported receiving from McKesson two sealed bottles of a product labeled as Triumeq that actually contained gemfibrozil. In September and October 2016, three Rite Aid pharmacies in Michigan reported receiving bottles of oxycodone hydrochloride that were instead filled with naproxen and, in one case, a combination of naproxen and ciprofloxacin hydrochloride. In December 2016, an Albertsons pharmacy reported receiving packages of divalproex and losartan potassium and hydrochlorothiazide that did not contain lot numbers or expiration dates.

Misconduct Type
Health
Enforcement Agency
Health and Human Services
Contracting Party
None
Court Type
N/A
Disposition
Investigative Finding
Date of Warning Letter
2/7/2019
Contractors Involved Penalty
Total
McKesson $0
Further Information Released
FDA Warning Letter 2/7/2019

Federal Contractor Misconduct Database